Ignitis Renewables brings first stage of Stelpe solar farm online in Latvia

Baiba Lace Country Manager at Ignitis Renewables Latvia LinkedIn
Baiba Lace Country Manager at Ignitis Renewables Latvia - LinkedIn
0Comments

Ignitis Renewables has announced that the first stage of its Stelpe solar farm in Latvia has reached commercial operation. The plant, located in Bauska municipality in southern Latvia, covers 85 hectares and is equipped with 121,000 solar panels. Its total installed capacity is 72.5 megawatts (MW).

Baiba Lāce, Head of Ignitis Renewables in Latvia, stated: “This project symbolizes our strong commitment to creating a green and secure energy ecosystem in Latvia and the entire region. This solar farm will help supply thousands of households with clean electricity, while also promoting local economic growth and strengthening community partnerships.”

The investment for the first phase of Stelpe solar farm I, including acquisition and construction costs, is expected to reach up to EUR 50 million. The facility will operate under market conditions, contributing renewable energy to the local supply.

Stelpe solar project consists of two sites with identical capacities of 72.5 MW each. It is one of three large-scale solar farms being developed by Ignitis Renewables in Latvia. The other projects include the Vārme solar farm (94 MW), which recently started operations, and the Tume solar farm project (174 MW), which remains under development. Combined, these three power plants will have an installed capacity exceeding 400 MW and are expected to provide renewable electricity for nearly 200,000 households annually.

Ignitis Renewables reports ongoing cooperation with local communities and municipalities during its projects’ development stages. The company implements financial support initiatives and maintains high environmental standards as part of its broader strategy to build a more reliable and sustainable energy system across the Baltic region.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.